AI Analysis AI Analysis of MRNA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MRNA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Weaker technical forecast for Moderna as stock downgraded to Strong Sell Candidate
(Updated on Jul 20, 2026)

Sell candidate since Jul 20, 2026

The Moderna stock price fell by -3.77% on the last day (Monday, 20th Jul 2026) from $61.82 to $59.49. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.25% from a day low at $59.31 to a day high of $62.43. The price has fallen in 7 of the last 10 days and is down by -27.27% for this period. Volume has increased on the last day by 103 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 5 million shares were bought and sold for approximately $271.94 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $56.84 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 42.06% during the next 3 months and, with a 90% probability hold a price between $80.75 and $122.13 at the end of this 3-month period.

MRNA Signals & Forecast

There are few to no technical positive signals at the moment. The Moderna stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $65.07 and $60.81. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -27.27%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Moderna stock

On the downside, the stock finds support just below today's level from accumulated volume at $55.40 and $54.35. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Moderna finds support just below today's level at $55.40. If this is broken, then the next support from accumulated volume will be at $54.35 and $52.88.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.12 between high and low, or 5.25%. For the last week, the stock has had daily average volatility of 4.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MRNA) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Moderna Inc. to open at $60.41, and during the day (based on 14 day Average True Range), to move between $57.19 and $61.79, which gives a possible trading interval of +/-$4.59 (+/-8.03%) up or down from last closing price. If Moderna Inc. takes out the full calculated possible swing range there will be an estimated 8.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $61.80 (3.88%) than the support at $55.40 (6.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Moderna Inc. stock A Buy?

The Moderna stock holds several negative signals and despite the positive trend, we believe Moderna will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

Current score: -5.184 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $60.41 ( 1.54%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MRNA Performance

Trading levels for MRNA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 63.52 6.78%
R2 62.33 4.78%
R1 61.60 3.54%
Price 59.49
S1 59.22 -0.457%
S2 58.48 -1.69%
S3 57.29 -3.69%

Accumulated Volume Support & Resistance Levels

Level Price
R3 67.27 13.08%
R2 63.96 7.51%
R1 61.80 3.88%
Price 59.49
S1 55.40 -6.88%
S2 54.35 -8.64%
S3 52.88 -11.11%

FAQ

What is the symbol for Moderna Stock and on which exchange is it traded?
The symbol for Moderna is MRNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Moderna Stock?
The Moderna stock holds several negative signals and despite the positive trend, we believe Moderna will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

How to buy Moderna Stock?
Moderna Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Moderna Stock.

What's the current price of Moderna Stock?
As of the end of day on the Jul 20, 2026, the price of an Moderna (MRNA) share was $59.49.

What is the 52-week high and low for Moderna Stock?
The 52-week high for Moderna Stock is $85.60 and the 52-week low is $22.29.

What is the market capitalization of Moderna Stock?
As of the Jul 20, 2026, the market capitalization of Moderna is 23.605B.

When is the next earnings date for Moderna?
The upcoming earnings date for Moderna is Jul 31, 2026.
Click to get the best stock tips daily for free!
ABOUT MODERNA INC.
Moderna
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
JLL
$299.78
8.73% Jun 24
NMRK
$15.02
3.26% Jun 24
NESR
$25.07
8.62% Jun 23
CAG
$13.43
9.20% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE